Literature DB >> 12097415

Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.

Ruth Fritsch1, Daniela Eselböck, Karl Skriner, Beatrice Jahn-Schmid, Clemens Scheinecker, Barbara Bohle, Makiyeh Tohidast-Akrad, Silvia Hayer, Josef Neumüller, Serafin Pinol-Roma, Josef S Smolen, Günter Steiner.   

Abstract

The role of autoimmune reactions in the pathogenesis of rheumatoid arthritis (RA) is poorly understood. To address this issue we have investigated the spontaneous T cell response to two well-characterized humoral autoantigens in RA patients and controls: 1) the heterogeneous nuclear ribonucleoprotein A2, i.e., the RA33 Ag (A2/RA33), and 2) filaggrin in unmodified and citrullinated forms. In stimulation assays A2/RA33 induced proliferative responses in PBMC of almost 60% of the RA patients but in only 20% of the controls (patients with osteoarthritis or psoriatic arthritis and healthy individuals), with substantially stronger responses in RA patients (p < 0.00002). Furthermore, synovial T cells of seven RA patients investigated were also clearly responsive. In contrast, responses to filaggrin were rarely observed and did not differ between RA patients and controls. Analysis of A2/RA33-induced cytokine secretion revealed high IFN-gamma and low IL-4 production in both RA and control PBMC, whereas IL-2 production was mainly observed in RA PBMC (p < 0.03). Moreover, A2/RA33-specific T cell clones from RA patients showed a strong Th1 phenotype and secreted higher amounts of IFN-gamma than Th1 clones from controls (p < 0.04). Inhibition experiments performed with mAbs against MHC class II molecules showed A2/RA33-induced T cell responses to be largely HLA-DR restricted. Finally, immunohistochemical analyses revealed pronounced overexpression of A2/RA33 in synovial tissue of RA patients. Taken together, the presence of autoreactive Th1-like cells in RA patients in conjunction with synovial overexpression of A2/RA33 may indicate potential involvement of this autoantigen in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097415     DOI: 10.4049/jimmunol.169.2.1068

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Antigen-specific T cells in rheumatoid arthritis.

Authors:  Sean R Bennett; Michael T Falta; Jerry Bill; Brian L Kotzin
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  In vivo identification of ribonucleoprotein-RNA interactions.

Authors:  Jennifer Zielinski; Kalle Kilk; Tiina Peritz; Theresa Kannanayakal; Kevin Y Miyashiro; Emelía Eiríksdóttir; Jeanine Jochems; Ulo Langel; James Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  The multiple facets of glucocorticoid action in rheumatoid arthritis.

Authors:  Ulrike Baschant; Nancy E Lane; Jan Tuckermann
Journal:  Nat Rev Rheumatol       Date:  2012-10-09       Impact factor: 20.543

4.  Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles.

Authors:  Diego Catalán; Octavio Aravena; Roberto Zúñiga; Natalia Silva; Alejandro Escobar; Francisca Sabugo; Pamela Wurmann; Lilian Soto; Rodrigo González; Jorge Alfaro; Milton Larrondo; Miguel Cuchacovich; Juan Carlos Aguillón
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

Review 5.  Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.

Authors:  Frits Koning; Ranjeny Thomas; Jamie Rossjohn; Rene E Toes
Journal:  Nat Rev Rheumatol       Date:  2015-05-19       Impact factor: 20.543

6.  Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

Authors:  V P K Nell; K P Machold; T A Stamm; G Eberl; H Heinzl; M Uffmann; J S Smolen; G Steiner
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

7.  Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Authors:  Inger Gjertsson; Karen L Laurie; James Devitt; Steven J Howe; Adrian J Thrasher; Rikard Holmdahl; Kenth Gustafsson
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

Review 8.  The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.

Authors:  Katleen Van Steendam; Kelly Tilleman; Dieter Deforce
Journal:  Rheumatology (Oxford)       Date:  2011-01-27       Impact factor: 7.580

Review 9.  Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

Authors:  C M U Hilkens; J D Isaacs
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

Review 10.  Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools.

Authors:  Günter Steiner
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.